article thumbnail

Alzheimer’s disease biomarkers galvanise rocky drug development space

Pharmaceutical Technology

By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services. The post Alzheimer’s disease biomarkers galvanise rocky drug development space appeared first on Pharmaceutical Technology.

article thumbnail

The Important Role that Biopharmaceutics Plays in Accelerating Early-Phase Drug Development

Pharmaceutical Technology

As formulators, we are often able to directly impact the amount of drug absorbed through formulation optimization and improve exposure. However, the chances of improving the exposure profile of a drug that is highly cleared by formulation modification are limited. S54 – S61 (2001).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Alzheimer’s disease biomarkers galvanize rocky drug development space

Pharmaceutical Technology

By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services. The post Alzheimer’s disease biomarkers galvanize rocky drug development space appeared first on Pharmaceutical Technology.

article thumbnail

MD Anderson and Xilis partner to expedite new cancer therapies development

Pharmaceutical Technology

It may offer opportunities for third-party collaborations to guide the new cell therapies and drugs development, if successful. It enables quick evaluation of a patient tumour response to a range of cancer drug modalities within 14 days of obtaining harvested samples of tumour cells.

article thumbnail

Six Trends to Watch in the New Healthcare Economy

Drug Channels

Karen examines trends in drug development, pricing, and healthcare. To learn more, download Six trends and tactics to thrive in the new healthcare economy , a free white paper from Wolters Kluwer. She also serves as co-chair of Maintenance and Control at the NCPDP. Read on for Karen’s insights.

article thumbnail

The rising importance of containment in small molecule drug development

Pharmaceutical Technology

HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. In the early stages of drug development, protecting operators from unknown risks is absolutely crucial.

article thumbnail

RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals

Pharmaceutical Technology

wants to ensure the ensuing the US does not lag behind other countries in drug development. We want to make sure we are getting rid of the regulatory impediments [that stop drugs getting to market],” RFK Jr stated. Tasos Katopodis / Stringer via Getty Images.